HK1250261A1 - 診斷阿爾茨海默症的方法 - Google Patents

診斷阿爾茨海默症的方法

Info

Publication number
HK1250261A1
HK1250261A1 HK18109705.7A HK18109705A HK1250261A1 HK 1250261 A1 HK1250261 A1 HK 1250261A1 HK 18109705 A HK18109705 A HK 18109705A HK 1250261 A1 HK1250261 A1 HK 1250261A1
Authority
HK
Hong Kong
Prior art keywords
alzheimer
diagnosis
disease
Prior art date
Application number
HK18109705.7A
Other languages
English (en)
Inventor
林佳靜
蔡澄偉
Original Assignee
百歐絲丹生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 百歐絲丹生物科技有限公司 filed Critical 百歐絲丹生物科技有限公司
Publication of HK1250261A1 publication Critical patent/HK1250261A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01012—Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) (1.2.1.12)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90203—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
HK18109705.7A 2016-10-26 2018-07-26 診斷阿爾茨海默症的方法 HK1250261A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/335,036 US11193933B2 (en) 2016-10-26 2016-10-26 Measuring GAPDH protein for diagnosis and treatment of alzheimer's disease

Publications (1)

Publication Number Publication Date
HK1250261A1 true HK1250261A1 (zh) 2018-12-07

Family

ID=61969495

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18109705.7A HK1250261A1 (zh) 2016-10-26 2018-07-26 診斷阿爾茨海默症的方法

Country Status (4)

Country Link
US (1) US11193933B2 (zh)
JP (1) JP6611753B2 (zh)
CN (1) CN107991490B (zh)
HK (1) HK1250261A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111198270B (zh) * 2018-11-16 2023-04-07 山东泽济生物科技有限公司 一种用于甘油醛-3-磷酸脱氢酶磁微粒化学发光检测试剂盒及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010080146A (ko) * 1998-10-13 2001-08-22 우에노 도시오 글리세릴알데히드-3-포스페이트 탈수소효소의 항체 및이의 용도
US20020172676A1 (en) 2001-05-16 2002-11-21 George Jackowski Method of treatment of alzheimer's disease and device therefor
US20040265849A1 (en) 2002-11-22 2004-12-30 Applera Corporation Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof
JP2005132738A (ja) * 2003-10-28 2005-05-26 Protein Express:Kk アルツハイマー病のタンパク質分子レベルにおける検出方法
JP2008506415A (ja) * 2004-07-19 2008-03-06 ユニバーシティー オブ ロチェスター 神経変性疾患の生物マーカー
DE102004052889A1 (de) * 2004-11-02 2006-05-11 Ruprecht-Karls-Universität Heidelberg Screeningverfahren zur Früherkennung des zerebralen Vasospasmus

Also Published As

Publication number Publication date
US20180113129A1 (en) 2018-04-26
US11193933B2 (en) 2021-12-07
CN107991490A (zh) 2018-05-04
JP2018072313A (ja) 2018-05-10
CN107991490B (zh) 2021-04-30
JP6611753B2 (ja) 2019-11-27

Similar Documents

Publication Publication Date Title
IL285722A (en) Methods for treating Alzheimer's disease
IL246917A0 (en) Biomarker and early diagnosis methods for Alzheimer's disease
IL247085A0 (en) Methods for treating Alzheimer's disease
ZA201605341B (en) Methods of treating alzheimer's disease
IL263433A (en) Methods for treating Alzheimer's disease
IL263188B (en) Treatment for Parkinson's disease
EP3537155A4 (en) METHOD FOR DETERMINING THE RISK OF MORBUS ALZHEIMER
HK1243709A1 (zh) 可用於治療阿爾茨海默氏病的四氫呋喃稠合的氨基氫噻嗪衍生物
HK1250261A1 (zh) 診斷阿爾茨海默症的方法
EP3310310A4 (en) DEVICE FOR TREATING MENIÈRE DISEASE
PL3449009T3 (pl) Biomarkery mikroRNA we krwi do diagnozowania choroby Alzheimera
ZA202001588B (en) Method of treating alzheimer's disease
HK1245081A1 (zh) 用於治療阿爾茨海默病的方法
EP3725882A4 (en) PROCEDURE TO ASSIST THE DIAGNOSIS OF ALZHEIMER'S MORBUS
ZA201807944B (en) Treatment for parkinson's disease
EP3601570A4 (en) METHOD FOR TREATMENT OF ALZHEIMER'S MORBUS
GB201511453D0 (en) Treatment of alzheimer's disease
EP3318874A4 (en) METHOD FOR DETERMINING THE RISK OF THE DEVELOPMENT OF MORBUS ALZHEIMER
GB201614863D0 (en) Alzheimer's disease
SG11201607693WA (en) 6-substituted estradiol derivatives for the treatment of alzheimer's disease
GB201417670D0 (en) Markers and methods for predicting prodromal stages of alzheimer's disease
GB201414038D0 (en) Alzheimer's disease